Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Cuts 3,000 Manufacturing Jobs, Pares Down Therapeutic Areas

Executive Summary

AstraZeneca's focus on improving manufacturing efficiencies, on the heels of similar moves by Merck and Pfizer, may signal that manufacturing is the next target for industry cost-cutting initiatives
Advertisement

Related Content

Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition
AstraZeneca Aims To Grow Seroquel XR With Added Indications, Not Switches
Aranesp Bad Luck Catches Up To Amgen, Forces Pharma-Style Reorganization
AstraZeneca expands jobs cuts
Astra Wins MedImmune Auction; $15.6 Billion Price Tag Raises Eyebrows
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Astra Values Entrepreneurial Spirit, Keeps R&D “Armies” Away From CAT
Pfizer’s Manufacturing Cost-Cutting May Leave Little Capacity For Growth
Merck Takes Cost-Cutting Therapy, But What Will The Side Effects Be?
Merck Takes Cost-Cutting Therapy, But What Will The Side Effects Be?
Advertisement
UsernamePublicRestriction

Register

PS047989

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel